176 related articles for article (PubMed ID: 8722242)
21. The importance of accidents in evaluating the cost of SSRIs: a review.
Hale AS
Int Clin Psychopharmacol; 1994 Sep; 9(3):195-201. PubMed ID: 7814829
[TBL] [Abstract][Full Text] [Related]
22. Economic outcomes associated with tricyclic antidepressant and selective serotonin reuptake inhibitor treatments for depression.
Crown WH
Acta Psychiatr Scand Suppl; 2000; 403():62-6. PubMed ID: 11019937
[TBL] [Abstract][Full Text] [Related]
23. Sertraline. A pharmacoeconomic evaluation of its use in depression.
Davis R; Wilde MI
Pharmacoeconomics; 1996 Oct; 10(4):409-31. PubMed ID: 10184609
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological treatment of depression with and without headache disorders: an appraisal of cost effectiveness and cost utility of antidepressants.
Pan YJ; Kuo KH; Wang SJ
J Affect Disord; 2015 Jan; 170():255-65. PubMed ID: 25261631
[TBL] [Abstract][Full Text] [Related]
25. Does the use of SSRIs reduce medical care utilization and expenditures?
Chung S
J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
[TBL] [Abstract][Full Text] [Related]
26. Study addresses question of preferred initial therapy for depression.
Am J Health Syst Pharm; 1996 Sep; 53(17):1994. PubMed ID: 8870882
[No Abstract] [Full Text] [Related]
27. Antidepressant agents: from tricyclics to serotonin uptake inhibitors.
Garattini S; Barbui C; Saraceno B
Psychol Med; 1998 Sep; 28(5):1169-78. PubMed ID: 9794024
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the cost-effectiveness of sertraline versus tricyclic antidepressants in primary care.
Forder J; Kavanagh S; Fenyo A
J Affect Disord; 1996 Jun; 38(2-3):97-111. PubMed ID: 8791179
[TBL] [Abstract][Full Text] [Related]
29. SSRIs versus tricyclics.
Rubinsztien JS; Michael A
Br J Psychiatry; 1996 Jul; 169(1):113-4. PubMed ID: 8818380
[No Abstract] [Full Text] [Related]
30. Economic outcomes with antidepressant pharmacotherapy: a retrospective intent-to-treat analysis.
Sclar DA; Skaer TL; Robison LM; Galin RS; Legg RF; Nemec NL
J Clin Psychiatry; 1998; 59 Suppl 2():13-7. PubMed ID: 9559755
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis.
MacGillivray S; Arroll B; Hatcher S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
BMJ; 2003 May; 326(7397):1014. PubMed ID: 12742924
[TBL] [Abstract][Full Text] [Related]
32. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song F; Freemantle N; Sheldon TA; House A; Watson P; Long A; Mason J
BMJ; 1993 Mar; 306(6879):683-7. PubMed ID: 8471919
[TBL] [Abstract][Full Text] [Related]
33. Assessment of clinical guidelines for continuation treatment in major depression.
Nuijten MJ
Value Health; 2001; 4(4):281-94. PubMed ID: 11705296
[TBL] [Abstract][Full Text] [Related]
34. [Antidepressants: TCA versus SSRI versus other new agents].
Hay F; Linkowski P
Rev Med Brux; 2004 Sep; 25(4):A315-20. PubMed ID: 15516063
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness and cost-effectiveness of antidepressant treatment in primary health care: a six-month randomised study comparing fluoxetine to imipramine.
Serrano-Blanco A; Gabarron E; Garcia-Bayo I; Soler-Vila M; Caramés E; Peñarrubia-Maria MT; Pinto-Meza A; Haro JM;
J Affect Disord; 2006 Apr; 91(2-3):153-63. PubMed ID: 16458976
[TBL] [Abstract][Full Text] [Related]
36. One-year costs of second-line therapies for depression.
Sullivan EM; Griffiths RI; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
J Clin Psychiatry; 2000 Apr; 61(4):290-8. PubMed ID: 10830151
[TBL] [Abstract][Full Text] [Related]
37. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
Perry PJ
J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
[TBL] [Abstract][Full Text] [Related]
38. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity.
Hotopf M; Hardy R; Lewis G
Br J Psychiatry; 1997 Feb; 170():120-7. PubMed ID: 9093499
[TBL] [Abstract][Full Text] [Related]
39. TCAs vs SSRIs. Same bang for whose buck?
Gallo JJ
Arch Fam Med; 1999; 8(4):326-7. PubMed ID: 10418539
[No Abstract] [Full Text] [Related]
40. Effect of antidepressant choice on the incidence and economic intensity of hospitalization among depressed individuals.
Croghan TW; Kniesner TJ; Melfi CA; Robinson RL
Adm Policy Ment Health; 2000 Mar; 27(4):183-95. PubMed ID: 10911668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
